Effect of inhaled toluene diisocyanate on local immune response based on murine model for occupational asthma

References

• Ban, M., Morel, G., Langonné, I., et al. 2006. TDI can induce respiratory allergy with TH2-dominated response in mice. Toxicology 218:29–47
   Google Scholar
• Boulet, L. P., Lemière, C., Gautrin, D., and Cartier, A. 2007. New insights into occupational asthma. Curr. Opin. Allergy Clin. Immunol. 7:96–101
   PubMed Web of Science ®Google Scholar
• Cassatella, M. A. 1995. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today 16:21–26
   PubMedGoogle Scholar
• Chan-Yeung, M., and Lam, S. 1986. Occupational asthma. Am. Rev. Respir. Dis. 133:686–703
   PubMed Web of Science ®Google Scholar
• de Vooght, V., Vanoirbeek, J. A., Luyts, K., et al. 2010. Choice of mouse strain influences the outcome in a mouse model of chemical-induced asthma. PLoS ONE. 5:e12581
   Google Scholar
• Dearman, R. J., Basketter, D. A., and Kimber, I. 1992. Variable effects of chemical allergens on serum IgE concentration in mice. Preliminary evaluation of a novel approach to the identification of respiratory sensitizers. J. Appl. Toxicol. 12:317–323
   PubMed Web of Science ®Google Scholar
• Dearman, R. J., Moussavi, A., Kemeny, D. M., and Kimber, I. 1996. Contribution of CD4+ and CD8+ T-lymphocyte subsets to cytokine secretion patterns induced in mice during sensitization to contact and respiratory chemical allergens. Immunology 89:502–510
   PubMed Web of Science ®Google Scholar
• Fabbri, L. M., Boschetto, P., Zoca, E., et al. 1987. Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am. Rev. Respir. Dis. 136:36–42
   PubMed Web of Science ®Google Scholar
• Fisseler-Eckhoff, A., Bartsch, H., Zinsky, R., and Schirren, J. 2011. Environmental isocyanate-induced asthma: Morphologic and pathogenetic aspects of an increasing occupational disease. Int. J. Environ. Res. Public Health 8:3672–3687
   PubMed Web of Science ®Google Scholar
• Gelfand, E. W. 2002. Pro: Mice are good model of human airway disease. Am. J. Respir. Crit. Care Med. 166:5–6
   PubMedGoogle Scholar
• Herrick, C. A., Xu, L., Wisnewski, A. V., et al. 2002. A novel mouse model of diisocyanate-induced asthma showing allergic-type inflammation in the lung after inhaled antigen challenge. J. Allergy Clin. Immunol. 109:873–878
   PubMed Web of Science ®Google Scholar
• Isenberg-Feig, H., Justice, J. P., and Keane-Myers, A. 2003. Animal models of allergic asthma. Curr. Allergy Asthma Rep. 3:70–78
   PubMed Web of Science ®Google Scholar
• Johnson, V. J., Matheson, J. M., and Luster, M. I. 2004. Animal models for diisocyanate asthma: Answer for lingering questions. Curr. Opin. Allergy Clin. Immunol. 4:105–110
   PubMed Web of Science ®Google Scholar
• Karol, M. H. 1991. Comparison of clinical and experimental data from an animal model of pulmonary immunologic sensitivity. Ann. Allergy 66:485–489
   PubMedGoogle Scholar
• Krug, N., Madden, J., Redington, A. E., et al. 1996. T-Cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Respir. Cell Mol. Biol. 14:319–326
   PubMed Web of Science ®Google Scholar
• Lee, S. H., Jang, A. S., Kwon, J. H., et al. 2011. Mesenchymal stem cell transfer suppresses airway remodeling in a toluene diisocyanate-induced murine asthma model. Allergy Asthma Immunol. Res. 3:205–211
   PubMedGoogle Scholar
• Lee, Y. C., Song, C. H., Lee, H. B., et al. 2001. A murine model of toluene diisocyanate-induced asthma can be treated with matrix metallo-proteinase inhibitor. J. Allergy Clin. Immunol. 108:1021–1026
   PubMed Web of Science ®Google Scholar
• Maestrelli, P., Del Prete, G. F., De Carli, M., et al. 1994. CD8 T-cell clones producing IL-5 and IFNγ in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand. J. Work Environ. Health 20:376–381
   PubMedGoogle Scholar
• Maestrelli, P., Occari, P., Turato, G., et al. 1997. Expression of IL-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI). Clin. Exp. Allergy 27:1292–1298
   PubMed Web of Science ®Google Scholar
• Magnan, A. O., Mely, L. G., Camilla, C. A., et al. 2000. Assessment of the TH1/TH2 paradigm in whole blood in atopy and asthma. Increased IFNγ-producing CD8+ T-cells in asthma. Am. J. Respir. Crit. Care Med. 161:1790–1796
   PubMed Web of Science ®Google Scholar
• Matheson, J. M., Johnson, V. J., and Luster, M. I. 2005. Immune mediators in a murine model for occupational asthma: Studies with toluene diisocyanate. Toxicol Sci. 84:99–109
   PubMed Web of Science ®Google Scholar
• Matheson, J. M., Lemus, R., Lange, R. W., et al. 2002. Role of TNF in toluene diisocyanate asthma. Am. J. Respir. Cell Mol. Biol. 27:396–405
   PubMed Web of Science ®Google Scholar
• NIOSH. 1996. Preventing asthma and death from diisocyanate exposure. Public Health Service, CDC/NIOSH Alert: 96–111. Atlanta, GA: NIOSH
   Google Scholar
• Oosterhout, A. J., and Nijkamp, F. P. 1993. Role of cytokines in bronchial hyper-responsiveness. Pulm. Pharmacol. 6:225–236
   PubMedGoogle Scholar
• Piirilä, P. L., Meuronen, A., Majuri, M. L., et al. 2008. Inflammation and functional outcome in diisocyanate-induced asthma after cessation of exposure. Allergy 63:583–591
   PubMed Web of Science ®Google Scholar
• Raulf-Heimsoth, M., and Baur, X. 1998. Patho-mechanisms and pathophysiology of isocyanate-induced diseases. Summary of present knowledge. Am. J. Ind. Med. 34:137–148
   PubMed Web of Science ®Google Scholar
• Redlich, C. A., and Karol, M. H. 2002. Diisocyanate asthma: Clinical aspects and immunopathogenesis. Int. Immunopharmacol. 2:213–224
   PubMed Web of Science ®Google Scholar
• Sastre, J., Vandenplas, O., and Park, H. S. 2003. Pathogenesis of occupational asthma. Eur. Resp. J. 22:364–373
   PubMedGoogle Scholar
• Scheerens, H., Buckley, T. L., Davidse, E. M., et al. 1996. Toluene diisocyanate-induced in vitro tracheal hyper-reactivity in the mouse. Am. J. Respir. Crit. Care Med. 154:858–865
   PubMed Web of Science ®Google Scholar
• Sećko, R. 2010. Documentation of maximum admissible values of occupational exposure. PiMOŚP 2(64). Warsaw: Central Institute for Labor Protection
   Google Scholar
• Sibille, Y., and Marchandise, F. X. 1993. Pulmonary immune cells in health and disease: Polymorphonuclear neutrophils. Eur. Resp. J. 6:1529–1543
   PubMed Web of Science ®Google Scholar
• Sun, L. Z., Elsayed, S., Bronstad, A. M., et al. 2006. Airway inflammation and bronchial remodeling in toluene diisocyanate-exposed BALB/c mouse model. Scan. J. Immunol. 65:118–125
   Google Scholar
• Świerczyńska-Machura, D., Walusiak-Skorupa, J., Nowakowska-Świrta, E., et al. 2012. Immunological determinants in a murine model of toluene diisocyanate-induced asthma. Int. J. Occup. Environ. Health 25:492–498
   Google Scholar
• Tarlo, S. M. 2003. Occupational asthma: A valid model for adult asthma? Curr. Opin. Allergy Clin. Immunol. 3:91–94
   PubMedGoogle Scholar
• Tse, C. S., Chen, S. E., and Bernstein, I. L. 1979. Induction of murine reaginic antibodies by toluene diisocyanate. An animal model of immediate hypersensitivity reactions to isocyanates. Am. Rev. Respir. Dis. 120:829–835
   PubMedGoogle Scholar
• Vanoirbeek, J. A., de Vooght, V., Nemery, B., and Hoet, P. H. 2009a. Multiple challenges in a mouse model of chemical-induced asthma lead to tolerance: Ventilatory and inflammatory responses are blunted, immunologic humoral responses are not. Toxicology 257:144–152
   PubMedGoogle Scholar
• Vanoirbeek, J. A., Tarkowski, M., de Vooght, V., et al. 2009b. Immunological determinants in a mouse model of chemical-induced asthma after multiple exposures. Scand. J. Immunol. 70:25–33
   PubMedGoogle Scholar
• van Rijt, L. S., and Lambrecht, B. N. 2001. Role of dendritic cells and TH2 lymphocytes in asthma: Lessons from eosinophilic airway inflammation in mouse. Miscrosc. Res. Tech. 53:256–272
   PubMed Web of Science ®Google Scholar
• Wisnewski, A. V., Herrick, C. A., Liu, Q., et al. 2003. Human γδ T-cell proliferation and IFNγ production induced by hexamethylene diisocyanate. J. Allergy Clin. Immunol. 112:538–546
   PubMedGoogle Scholar
• Wisnewski, A. V., Liu, Q., Liu, J., and Redlich, C. A. 2008. Human innate immune responsem to hexa-methylene diisocyanate (HDI) and HDI-albumin cojugates. Clin. Exp. Allergy 38:957–967
   PubMed Web of Science ®Google Scholar
• Wisniewski, A. V., Redlich, C. A., Mapp, C. E., and Bernstein, D. I., (Eds.). 2006. Poly-isocyanates and their pre-polymers. In: Asthma in the Workplace, 3rd Edition. New York: Taylor and Francis Group, pp. 481–504
   Google Scholar